# The Role of the JAK-STAT Signaling Pathway in the Protective Effects of Hepatic Ischemia Post-conditioning Against the Injury Induced by Ischemia/Reperfusion in the Rat Liver

**Authors:** Neda Ghasemi Pour Afshar, Hossein Ali Arab, Akram Vatannejad, Ghorbangol Ashabi, Ali akbar Golabchifar

PMC · DOI: 10.34172/apb.2024.003 · Advanced Pharmaceutical Bulletin · 2023-07-19

## TL;DR

This study shows that hepatic ischemia post-conditioning protects the liver from injury by activating the IL-6-JAK-STAT pathway.

## Contribution

The study identifies the IL-6-JAK-STAT pathway as a mediator of the protective effects of hepatic IPOC against IR injury.

## Key findings

- Hepatic IPOC reduced liver injury markers like AST, ALT, and IL-6 levels.
- TOFA blocked the protective effects of IPOC, suggesting JAK-STAT pathway involvement.
- IPOC downregulated the Bax/Bcl-2 ratio, indicating reduced apoptosis.

## Abstract

Hepatic ischemic post-conditioning (IPOC) is shown to protect the liver from injury induced by ischemia/reperfusion (IR). However, the mechanism underlying this protection has remained elusive. The present study aimed to investigate the role of the interleukin 6-Janus kinase-signal transducers and activators of transcription (IL-6-JAK-STAT) pathway in the protective effect of hepatic IPOC against the IR-induced injury in the liver.

Twenty-five rats were randomly divided into 5 groups of (1) sham-operated, (2) IR, (3) IR+hepatic IPOC, (4) IR+tofacitinib (TOFA), and (5) IR+TOFA+hepatic IPOC. The changes induced by IR and the effects of different treatments were assessed by enzyme release, histopathological observations, the serum level of IL-6, and the occurrence of apoptosis detected via the expression of the Bax/Bcl-2 ratio.

The hepatic IPOC improved the liver injury induced by IR as shown by histological changes, reduction of IL-6 level, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) compared to the IR group (P<0.001, P<0.05, P<0.05, respectively). There was also downregulation of the Bax/Bcl2 ratio in the rats exposed to IR+hepatic IPOC compared with those in the IR group (P<0.05). However, TOFA, an inhibitor of JAK-STAT activity, inhibited the protective effect of hepatic IPOC.

It suggests that the protective effect of hepatic IPOC against IR-induced injury may be mediated by activating the IL-6-JAK-STAT pathway.

## Linked entities

- **Proteins:** IL6 (interleukin 6), BAX (BCL2 associated X, apoptosis regulator), BCL2 (BCL2 apoptosis regulator), jak (Janus kinase), SOAT1 (sterol O-acyltransferase 1)
- **Chemicals:** tofacitinib (PubChem CID 9926791), alanine aminotransferase (PubChem CID 251717)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}
- **Diseases:** Hepatic ischemic (MESH:D000081011), Liver (MESH:D017093), Hepatic Ischemia (MESH:D007511), Injury (MESH:D014947)
- **Chemicals:** TOFA (-), tofacitinib (MESH:C479163)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10997924/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10997924/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC10997924/full.md

---
Source: https://tomesphere.com/paper/PMC10997924